197 Novel FcyR recombinant fusion facilitates antibody arming of engineered iPSC-derived NK cells to enhance targeting and killing of ovarian cancer cells

Kristin Snyder; Kate Dixon; Melissa Khaw; Zachary Davis; Paul Rogers; Martin Hosking; Ryan Bjordahl; Bahram Valamehr; Jianming Wu; Bruce Walcheck

doi:10.1136/jitc-2021-SITC2021.197

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF

Regular and Young Investigator Award Abstracts

Cellular Therapies

197 Novel FcyR recombinant fusion facilitates antibody arming of engineered iPSC-derived NK cells to enhance targeting and killing of ovarian cancer cells

Free

Online download statistics by month:

Online download statistics by month: November 2021 to February 2023

	Abstract	Pdf
Nov 2021	337	40
Dec 2021	74	16
Jan 2022	52	23
Feb 2022	68	19
Mar 2022	386	30
Apr 2022	140	21
May 2022	68	17
Jun 2022	60	25
Jul 2022	44	7
Aug 2022	78	4
Sep 2022	69	16
Oct 2022	74	8
Nov 2022	84	12
Dec 2022	54	6
Jan 2023	78	17
Feb 2023	66	6
Total	1732	267

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online download statistics by month:

Online download statistics by month: November 2021 to February 2023

Read the full text or download the PDF:

Log in using your username and password